CellaVision
OM:CEVI Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 15 Fair Values set on narratives written by author
WA
Consensus Narrative from 4 Analysts
Next-generation Digital Cell Morphology Analyzer Will Drive Future Product Development
Key Takeaways Strategic alignment with Sysmex and innovation are driving growth, enhancing revenue and future earnings potential. Diversification and technology investments, including methanol-free products and new applications, aim to expand revenue streams and improve margins.
View narrativeSEK 242.50
FV
19.2% undervalued intrinsic discount12.98%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
6 days ago author updated this narrative